Alpha-Galactosidase

α-galactosidase (EC 3.2.1.22)
Evidence Level
Strong
2 Clinical Trials
3 Documented Benefits
4/5 Evidence Score

Alpha-galactosidase is the active enzyme in Beano® and similar gas-prevention supplements. It hydrolyzes the α-1,6 galactosyl bonds in raffinose, stachyose, and verbascose — complex oligosaccharides found in beans, lentils, peas, and cruciferous vegetables (broccoli, cabbage, Brussels sprouts) that humans cannot digest. Without supplementation, these sugars reach the colon undigested where bacteria ferment them, producing the gas, bloating, and discomfort associated with these foods. Most commercially available alpha-galactosidase is derived from the food-grade fungus Aspergillus niger.

Studied Dose 150–300 GalU per food serving; typical Beano® dose is 150 GalU per tablet at first bite
Active Compound Alpha-galactosidase enzyme (measured in GalU — Galactosidase Units)

Reduced gas, bloating, and abdominal pain from beans, legumes, and cruciferous vegetables

A 2007 randomized double-blind crossover trial (Di Stefano et al.) demonstrated that alpha-galactosidase taken with a high-FODMAP meal (containing 12g raffinose-family oligosaccharides) significantly reduced post-meal hydrogen breath test elevation (a marker of bacterial fermentation), flatulence frequency, abdominal distension, and gas-related discomfort vs. placebo. Original studies by Ganiats et al. (1994) demonstrated similar effects with bean meals.

Practical FODMAP-tolerance support

Alpha-galactosidase enables individuals with FODMAP sensitivity or IBS to enjoy nutritious legume-rich and cruciferous-rich foods (high-fiber, plant protein, B vitamins, antioxidants) that they would otherwise need to restrict. Many low-FODMAP enzyme blends (FODZYME®, FodMate) include alpha-galactosidase as a primary component.

Reduced functional dyspepsia symptoms in mixed meal contexts

Beyond pure legume meals, alpha-galactosidase reduces post-meal gas symptoms when included in broader digestive enzyme blends. Particularly valuable for individuals with low gut microbial diversity who experience excessive fermentation of complex carbohydrates.

1

Hydrolysis of α-1,6 galactosyl bonds in raffinose-family oligosaccharides

Alpha-galactosidase cleaves the α-1,6 glycosidic bond connecting galactose to other sugars in raffinose (galactose-glucose-fructose), stachyose (galactose-galactose-glucose-fructose), and verbascose (galactose-galactose-galactose-glucose-fructose). Humans lack endogenous alpha-galactosidase enzymes capable of digesting these compounds — they pass to the colon where Bacteroides and Bifidobacterium species ferment them, producing CO2, hydrogen, and methane gases.

2

Acid stability and small intestine activity

Aspergillus niger-derived alpha-galactosidase is acid-stable (active at pH 3–7) and can begin working in the stomach and continue throughout the small intestine. This provides a broader window of activity compared to pH-sensitive enzymes that only work at neutral pH.

3

Substrate-specific — minimal effect on other dietary components

Unlike broad-spectrum digestive enzyme blends, alpha-galactosidase is highly substrate-specific. It targets only the raffinose-family oligosaccharides without affecting protein, fat, starch, or other carbohydrate digestion. This means it can be taken safely with many medications and other supplements without interfering.

1
Alpha-Galactosidase for Gas and Symptoms After Bean Meal — RCT
PubMed

Double-blind, randomized, placebo-controlled crossover trial. Subjects consumed 1/2 cup of cooked pinto beans with placebo or alpha-galactosidase tablet (300 GalU). Hydrogen breath testing and symptom scoring over 5 hours.

19 healthy adults sensitive to beans.

Hydrogen breath test peak reduced from 88 to 32 ppm with enzyme (-64%). Subjects scored significantly less abdominal cramping, bloating, and flatulence. Established alpha-galactosidase as effective for legume-induced gas. Foundational study for Beano®.

2
Alpha-Galactosidase for IBS-Type Symptoms After High-FODMAP Meal
PubMed

Double-blind, randomized, crossover trial. 8 IBS patients ate test meal with 12 g raffinose-family oligosaccharides with alpha-galactosidase or placebo. Symptoms scored over 8 hours.

8 IBS patients with documented oligosaccharide intolerance.

Significant reductions in flatulence (-60%), abdominal distension, and discomfort with alpha-galactosidase. Hydrogen breath test responses also significantly reduced, confirming reduced bacterial fermentation.

Common Potential side effects

Generally extremely well-tolerated; well-established OTC enzyme
Contains small amounts of galactose post-hydrolysis — caution in galactosemia (very rare metabolic disorder)
Diabetics: alpha-galactosidase frees small amounts of glucose, galactose, and fructose from oligosaccharides — minor blood sugar impact (clinically insignificant in most cases)

Important Drug interactions

No clinically significant drug interactions
Caution in galactosemia (extremely rare metabolic disorder where galactose accumulates)
Compatible with most medications and digestive enzyme blends